Abbott has previously signalled interest in medical device sector
Pharma giant joins wave of dealmaking sweeping the health-care industry
Profit benefited from lower-than-expected research and development costs and other spending in the quarter
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices